C3.ai (NYSE:AI) Price Target Raised to $17.00
C3.ai (NYSE:AI – Free Report) had its target price boosted by UBS Group from $16.00 to $17.00 in a report published on Friday morning,Benzinga reports. They currently have a neutral rating on the stock. Other equities analysts have also issued reports about the stock. Westpark Capital upgraded shares of C3.ai to a “strong-buy” rating and […]
OR Royalties (NYSE:OR) Price Target Raised to $36.00
OR Royalties (NYSE:OR – Free Report) had its price objective hoisted by Raymond James Financial from $34.00 to $36.00 in a research report report published on Friday morning,Benzinga reports. They currently have an outperform rating on the basic materials company’s stock. Other equities analysts have also issued research reports about the company. Wall Street Zen […]
Chevron (NYSE:CVX) Price Target Cut to $191.00 by Analysts at Mizuho
Chevron (NYSE:CVX – Get Free Report) had its price target reduced by Mizuho from $192.00 to $191.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the oil and gas company’s stock. Mizuho’s target price would suggest a potential upside of 20.69% from the stock’s current […]
aTyr Pharma’s (ATYR) Market Perform Rating Reaffirmed at Leerink Partners
aTyr Pharma (NASDAQ:ATYR – Get Free Report)‘s stock had its “market perform” rating reiterated by Leerink Partners in a note issued to investors on Monday, Marketbeat Ratings reports. Several other equities research analysts have also commented on ATYR. Jefferies Financial Group boosted their price target on aTyr Pharma from $9.00 to $17.00 and gave the […]
Marqeta, Inc. (NASDAQ:MQ) Receives $6.11 Consensus Target Price from Analysts
Marqeta, Inc. (NASDAQ:MQ – Get Free Report) has been given an average rating of “Hold” by the thirteen analysts that are currently covering the company, Marketbeat.com reports. Ten analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among analysts […]
Sportradar Group (NASDAQ:SRAD) Earns Buy Rating from Analysts at Roth Capital
Roth Capital initiated coverage on shares of Sportradar Group (NASDAQ:SRAD – Free Report) in a research note published on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $40.00 price target on the stock. SRAD has been the subject of several other research reports. Arete initiated coverage on shares of Sportradar Group […]
VICI Properties (NYSE:VICI) Price Target Raised to $38.00 at Evercore ISI
VICI Properties (NYSE:VICI – Get Free Report) had its price target increased by equities researchers at Evercore ISI from $37.00 to $38.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Evercore ISI’s price objective indicates a potential upside of 14.48% from the stock’s current […]
aTyr Pharma (NASDAQ:ATYR) Receives “Market Perform” Rating from Leerink Partners
aTyr Pharma (NASDAQ:ATYR – Get Free Report)‘s stock had its “market perform” rating reissued by Leerink Partners in a research note issued to investors on Monday. A number of other research analysts have also recently weighed in on the company. Wall Street Zen cut aTyr Pharma from a “hold” rating to a “sell” rating in […]
Analysts Set Li Auto Inc. Sponsored ADR (NASDAQ:LI) Price Target at $26.26
Li Auto Inc. Sponsored ADR (NASDAQ:LI – Get Free Report) has earned a consensus rating of “Reduce” from the fourteen ratings firms that are currently covering the company, MarketBeat.com reports. Four analysts have rated the stock with a sell rating, eight have given a hold rating, one has issued a buy rating and one has […]
aTyr Pharma (NASDAQ:ATYR) Earns “Market Perform” Rating from Leerink Partners
aTyr Pharma (NASDAQ:ATYR – Get Free Report)‘s stock had its “market perform” rating reiterated by research analysts at Leerink Partners in a report released on Monday, MarketBeat reports. A number of other brokerages also recently issued reports on ATYR. Jefferies Financial Group lifted their price target on shares of aTyr Pharma from $9.00 to $17.00 […]
aTyr Pharma (NASDAQ:ATYR) Given “Market Perform” Rating at Leerink Partners
aTyr Pharma (NASDAQ:ATYR – Get Free Report)‘s stock had its “market perform” rating reissued by stock analysts at Leerink Partners in a research report issued to clients and investors on Monday, Marketbeat reports. Other equities analysts have also recently issued reports about the stock. Jefferies Financial Group upped their price objective on shares of aTyr […]
HC Wainwright Boosts Maze Therapeutics (NASDAQ:MAZE) Price Target to $50.00
Maze Therapeutics (NASDAQ:MAZE – Free Report) had its price target raised by HC Wainwright from $34.00 to $50.00 in a report released on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. MAZE has been the topic of several other reports. Wall Street Zen upgraded Maze Therapeutics from a “sell” rating to […]
CommScope Holding Company, Inc. (NASDAQ:COMM) Receives $14.75 Consensus PT from Analysts
CommScope Holding Company, Inc. (NASDAQ:COMM – Get Free Report) has received an average rating of “Moderate Buy” from the nine analysts that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating […]
Paymentus Holdings, Inc. (NYSE:PAY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Paymentus Holdings, Inc. (NYSE:PAY – Get Free Report) have earned an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month […]
Financial Review: Sportradar Group (NASDAQ:SRAD) & Massimo Group (NASDAQ:MAMO)
Sportradar Group (NASDAQ:SRAD – Get Free Report) and Massimo Group (NASDAQ:MAMO – Get Free Report) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation. Earnings and Valuation This table compares Sportradar […]
last updated on 15 Sep 22:27